Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2013

Study Completion Date

June 5, 2013

Conditions
Multiple Myeloma
Interventions
DRUG

zoledronic acid

Zoledronic acid 4 mg every 4 weeks for a total of 12 treatments

OTHER

No treatment control

Patients doesn't receive treatment

Trial Locations (16)

Unknown

Hospital Universitari Germans Trias I Pujol, Badalona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital del Mar, Barcelona

Hospital Vall d'Hebrón, Barcelona

Hospital Clínico San Carlos, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Jose María Morales Meseguer, Murcia

Hospital Central de Asturias, Oviedo

Hospital Son Llàtzer, Palma de Mallorca

Hospital Universitario Son Dureta, Palma de Mallorca

Hospital Universitario de Salamanca, Salamanca

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital Clínico Universitario de Valencia, Valencia

Hospital Universitario Dr. Peset., Valencia

Hospital Universitario La Fe, Valencia

Hospital Clínico Lozano Blesa, Zaragoza

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Dynamic Solutions

INDUSTRY

collaborator

Novartis

INDUSTRY

lead

PETHEMA Foundation

OTHER